Russell Investments Group, Ltd. Syndax Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 13,514 shares of SNDX stock, worth $184,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,514

Previous 13,283 1.74%

Holding current value

$184,195

Previous $272,000 4.41%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.93 - $24.81 $4,141 - $5,731	231 Added 1.74%	13,514 $260,000
Q2 2024 Aug 08, 2024	BUY	$18.82 - $23.79 $54,032 - $68,301	2,871 Added 27.57%	13,283 $272,000
Q1 2024 May 08, 2024	SELL	$19.71 - $24.57 $131,544 - $163,980	-6,674 Reduced 39.06%	10,412 $247,000
Q4 2023 Feb 05, 2024	SELL	$11.39 - $21.67 $19,499 - $37,099	-1,712 Reduced 9.11%	17,086 $369,000
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $149,526 - $224,187	10,298 Added 121.15%	18,798 $272,000
Q2 2023 Aug 10, 2023	BUY	$19.35 - $22.31 $164,475 - $189,635	8,500 New	8,500 $177,000
Q4 2022 Feb 08, 2023	BUY	$20.64 - $26.24 $817,240 - $1.04 Million	39,595 New	39,595 $1.01 Million
Q3 2021 Nov 08, 2021	SELL	$13.87 - $19.8 $21,013 - $29,997	-1,515 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$13.42 - $25.18 $839,917 - $1.58 Million	-62,587 Reduced 97.64%	1,515 $26,000
Q1 2021 May 10, 2021	SELL	$19.28 - $24.59 $823,005 - $1.05 Million	-42,687 Reduced 39.97%	64,102 $1.43 Million
Q4 2020 Feb 08, 2021	SELL	$15.1 - $26.44 $275,529 - $482,450	-18,247 Reduced 14.59%	106,789 $2.38 Million
Q3 2020 Nov 09, 2020	BUY	$13.39 - $17.48 $280,038 - $365,576	20,914 Added 20.09%	125,036 $1.84 Million
Q2 2020 Aug 05, 2020	SELL	$8.94 - $20.98 $271,123 - $636,260	-30,327 Reduced 22.56%	104,122 $1.54 Million
Q1 2020 May 06, 2020	BUY	$6.65 - $12.03 $894,085 - $1.62 Million	134,449 New	134,449 $1.47 Million
Q1 2019 May 13, 2019	SELL	$4.26 - $6.86 $8,520 - $13,720	-2,000 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$3.6 - $8.42 $6,840 - $15,998	-1,900 Reduced 48.72%	2,000 $9,000
Q3 2018 Oct 26, 2018	SELL	$6.33 - $8.08 $633 - $808	-100 Reduced 2.5%	3,900 $32,000
Q2 2018 Aug 08, 2018	BUY	$6.93 - $14.63 $27,720 - $58,520	4,000 New	4,000 $28,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $771M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Syndax Pharmaceuticals Inc Transaction History